204 related articles for article (PubMed ID: 36433934)
1. Translational readthrough of nonsense mutant TP53 by mRNA incorporation of 5-Fluorouridine.
Palomar-Siles M; Heldin A; Zhang M; Strandgren C; Yurevych V; van Dinter JT; Engels SAG; Hofman DA; Öhlin S; Meineke B; Bykov VJN; van Heesch S; Wiman KG
Cell Death Dis; 2022 Nov; 13(11):997. PubMed ID: 36433934
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of
Strandgren C; Wiman KG
Ups J Med Sci; 2024; 129():. PubMed ID: 38863730
[TBL] [Abstract][Full Text] [Related]
3. Novel compounds that synergize with aminoglycoside G418 or eRF3 degraders for translational readthrough of nonsense mutant
Heldin A; Cancer M; Palomar-Siles M; Öhlin S; Zhang M; Sun-Zhang A; Mariani A; Liu J; Bykov VJN; Wiman KG
RNA Biol; 2023 Jan; 20(1):368-383. PubMed ID: 37339263
[TBL] [Abstract][Full Text] [Related]
4. The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418.
Ferguson MW; Gerak CAN; Chow CCT; Rastelli EJ; Elmore KE; Stahl F; Hosseini-Farahabadi S; Baradaran-Heravi A; Coltart DM; Roberge M
PLoS One; 2019; 14(5):e0216423. PubMed ID: 31120902
[TBL] [Abstract][Full Text] [Related]
5. Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells.
Bidou L; Bugaud O; Belakhov V; Baasov T; Namy O
RNA Biol; 2017 Mar; 14(3):378-388. PubMed ID: 28145797
[TBL] [Abstract][Full Text] [Related]
6. Synergistic Rescue of Nonsense Mutant Tumor Suppressor p53 by Combination Treatment with Aminoglycosides and Mdm2 Inhibitors.
Zhang M; Heldin A; Palomar-Siles M; Öhlin S; Bykov VJN; Wiman KG
Front Oncol; 2017; 7():323. PubMed ID: 29354595
[TBL] [Abstract][Full Text] [Related]
7. The nucleoside analog clitocine is a potent and efficacious readthrough agent.
Friesen WJ; Trotta CR; Tomizawa Y; Zhuo J; Johnson B; Sierra J; Roy B; Weetall M; Hedrick J; Sheedy J; Takasugi J; Moon YC; Babu S; Baiazitov R; Leszyk JD; Davis TW; Colacino JM; Peltz SW; Welch EM
RNA; 2017 Apr; 23(4):567-577. PubMed ID: 28096517
[TBL] [Abstract][Full Text] [Related]
8. Novel small molecules potentiate premature termination codon readthrough by aminoglycosides.
Baradaran-Heravi A; Balgi AD; Zimmerman C; Choi K; Shidmoossavee FS; Tan JS; Bergeaud C; Krause A; Flibotte S; Shimizu Y; Anderson HJ; Mouly V; Jan E; Pfeifer T; Jaquith JB; Roberge M
Nucleic Acids Res; 2016 Aug; 44(14):6583-98. PubMed ID: 27407112
[TBL] [Abstract][Full Text] [Related]
9. Readthrough Approach Using NV Translational Readthrough-Inducing Drugs (TRIDs): A Study of the Possible Off-Target Effects on Natural Termination Codons (NTCs) on TP53 and Housekeeping Gene Expression.
Perriera R; Vitale E; Pibiri I; Carollo PS; Ricci D; Corrao F; Fiduccia I; Melfi R; Zizzo MG; Tutone M; Pace A; Lentini L
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894764
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological induction of translational readthrough of nonsense mutations in the retinoblastoma (RB1) gene.
Palomar-Siles M; Yurevych V; Bykov VJN; Wiman KG
PLoS One; 2023; 18(11):e0292468. PubMed ID: 37917619
[TBL] [Abstract][Full Text] [Related]
11. Gentamicin B1 is a minor gentamicin component with major nonsense mutation suppression activity.
Baradaran-Heravi A; Niesser J; Balgi AD; Choi K; Zimmerman C; South AP; Anderson HJ; Strynadka NC; Bally MB; Roberge M
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3479-3484. PubMed ID: 28289221
[TBL] [Abstract][Full Text] [Related]
12. Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy.
Howard MT; Shirts BH; Petros LM; Flanigan KM; Gesteland RF; Atkins JF
Ann Neurol; 2000 Aug; 48(2):164-9. PubMed ID: 10939566
[TBL] [Abstract][Full Text] [Related]
13. Molecular Insights into Determinants of Translational Readthrough and Implications for Nonsense Suppression Approaches.
Lombardi S; Testa MF; Pinotti M; Branchini A
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322589
[TBL] [Abstract][Full Text] [Related]
14. Rescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides.
Floquet C; Deforges J; Rousset JP; Bidou L
Nucleic Acids Res; 2011 Apr; 39(8):3350-62. PubMed ID: 21149266
[TBL] [Abstract][Full Text] [Related]
15. Pseudouridine-mediated stop codon readthrough in
Adachi H; Yu YT
RNA; 2020 Sep; 26(9):1247-1256. PubMed ID: 32434780
[TBL] [Abstract][Full Text] [Related]
16. Factors Affecting Readthrough of Natural Versus Premature Termination Codons.
Beryozkin A; Nagel-Wolfum K; Banin E; Sharon D
Adv Exp Med Biol; 2023; 1415():149-155. PubMed ID: 37440028
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of premature stop codon readthrough in the CFTR gene by Ataluren (PTC124) derivatives.
Pibiri I; Lentini L; Melfi R; Gallucci G; Pace A; Spinello A; Barone G; Di Leonardo A
Eur J Med Chem; 2015 Aug; 101():236-44. PubMed ID: 26142488
[TBL] [Abstract][Full Text] [Related]
18. Small molecule Y-320 stimulates ribosome biogenesis, protein synthesis, and aminoglycoside-induced premature termination codon readthrough.
Hosseini-Farahabadi S; Baradaran-Heravi A; Zimmerman C; Choi K; Flibotte S; Roberge M
PLoS Biol; 2021 May; 19(5):e3001221. PubMed ID: 33939688
[TBL] [Abstract][Full Text] [Related]
19. Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression.
Roy B; Friesen WJ; Tomizawa Y; Leszyk JD; Zhuo J; Johnson B; Dakka J; Trotta CR; Xue X; Mutyam V; Keeling KM; Mobley JA; Rowe SM; Bedwell DM; Welch EM; Jacobson A
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12508-12513. PubMed ID: 27702906
[TBL] [Abstract][Full Text] [Related]
20. Readthrough of ACTN3 577X nonsense mutation produces full-length α-actinin-3 protein.
Harada N; Hatakeyama A; Okuyama M; Miyatake Y; Nakagawa T; Kuroda M; Masumoto S; Tsutsumi R; Nakaya Y; Sakaue H
Biochem Biophys Res Commun; 2018 Jul; 502(3):422-428. PubMed ID: 29857001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
